Molecular classification of human carcinomas by use of gene expression signatures

Cancer Research

Volumn 61, Issue 20, 2001, Pages 7388-7393

  Su, Andrew I ^a   Welsh, John B ^b   Sapinoso, Lisa M ^b   Kern, Suzanne G ^b   Dimitrov, Petre ^b   Lapp, Hilmar ^b   Schultz, Peter G ^a,b   Powell, Steven M ^c   Moskaluk, Christopher A ^c   Frierson, Henry F ^c   Hampton, Garret M ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Genomics Institute of the Novartis Research Foundation   (Germany)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; COLORECTAL CANCER; GENE EXPRESSION SYSTEM; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; NUCLEOTIDE SEQUENCE; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; RNA, NEOPLASM;

EID: 0035887459     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hillen H. F. Unknown primary tumors. Postgrad. Med. J., 76: 690-693, 2000.
2. Greenlee R. T., Hill-Harmon M. B., Murray T., Thun M. Cancer Statistics, 2001. CA Cancer J. Clin., 51: 15-36, 2001.
3. Welsh J. B., Zarrinkar P. P., Sapinoso L. M., Kern S. G., Behling C. A., Monk B. J., Lockhart D. J., Burger R. A., Hampton G. H. Analysis of gene expression in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. USA, 98: 1176-1181, 2001.
4. Welsh J. B., Sapinoso L. M., Su A. I., Kern S. G., Wang-Rodriguez J., Moskaluk C. A., Frierson H. F., Jr., Hampton G. M. Analysis of gene expression identifies candidate makers and pharmacologic targets in prostate cancer. Cancer Res., 61: 5974-5978, 2001.
5. Lockhart D. J., Dong H., Byrne M. C., Follettie K. T., Gallo M. V., Chee M. S., Mittmann M., Wang C., Kobayashi M., Horton H., Brown E. L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol., 14: 1675-1680, 1996.
6. Wodicka L., Dong H., Mittmann M., Ho M-H., Lockhart D. J. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat. Biotechnol., 15: 1359-1367, 1997.
7. Hollander M., Wolfe D. A. Nonparametric Statistical Inference John Wiley & Sons New York, 1973.
8. Vapnik V. N. The Nature of Statistical Learning Theory Springer-Verlag Berlin 1995.
9. Stone M. Cross-validation choice and assessment of statistical predictions. J. R. Stat. Soc., B-36: 111-114, 1974.
10. Efron B., Tibshirani R. An Introduction to the Bootstrap Chapman & Hall New York 1993.
11. Greller L. D., Tobin F. L. Detecting selective expression of genes and proteins. Genome Res., 9: 282-296, 1999.
12. Eisen M. B., Spellman P. T., Brown P. O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
13. Furey T. S., Cristianini N., Duffy N., Bednarski D. W., Schummer M., Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics, 16: 906-914, 2000.
14. Tschmelitsch J., Barendswaard E., Williams C. J., Yao T. J., Cohen A. M., Old L. J., Welt S. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil). Cancer Res., 57: 2181-2186, 1997.
15. Ghossein R. A., Carusone L., Bhattacharya S. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas. In Vivo, 14: 237-250, 2000.
16. Reis-Filho J. S., Carrilho C., Valenti C., Leitao D., Ribeiro C. A., Ribeiro S. G., Schmitt F. C. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?. Pathol. Res. Pract., 196: 835-840, 2000.
17. Li S. M., Zhang Z. T., Chan S., McLenan O., Dixon C., Taneja S., Lepor H., Sun T. T., Wu X. R. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder. J. Urol., 162: 931-935, 1999.
18. Kelly T., Kechelava S., Rozypal T. L., West K. W., Korourian S. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod. Pathol., 11: 855-861, 1998.
19. Diamandis E. P., Yousef G. M., Soosaipillai A. R., Bunting P. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin. Biochem., 33: 579-583, 2000.
20. Hassan R., Viner J. L., Wang Q. C., Margulies I., Kreitman R. J., Pastan I. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. J. Immunother., 20: 2902-2906, 2000.
21. Golub T. R., Slonim D. K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J. P., Coller H., Loh M. L., Downing J. R., Caligiuri M. A., Bloomfield C. D., Lander E. S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (Wash. DC), 286: 531-537, 1999.
22. Hedenfalk I., Duggan D., Chen Y., Radmacher M., Bittner M., Simon R., Meltzer P., Gusterson B., Esteller M., Kallioniemi O. P., Wilfond B., Borg A., Trent J. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med., 344: 539-548, 2001.
23. Khan J., Wei J. S., Ringner M., Saal L. H., Ladanyi M., Westermann F., Berthold F., Schwab M., Antonescu C. R., Peterson C., Meltzer P. S. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med., 7: 673-679, 2001.
24. Yeang C-H., Ramaswamy S., Tamayo P., Mukherjee S., Rifkin R. M., Angelo M., Reich M., Lander E., Mesirov J., Golub T. Molecular classification of multiple tumor types. Bioinformatics, 17 (Suppl. 1): s316-s322, 2001.